209 related articles for article (PubMed ID: 24969866)
1. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.
Wang YD; Zhai WL; Wang HY; Xia XQ
Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866
[TBL] [Abstract][Full Text] [Related]
2. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.
Li J; Li Z; Feng L; Guo W; Zhang S
Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199
[TBL] [Abstract][Full Text] [Related]
4. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
Qi Y; Cui L; Song Y; Li N
Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
[TBL] [Abstract][Full Text] [Related]
5. Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis.
Wang Y; Chu X; Meng X; Zou F
PLoS One; 2013; 8(10):e77898. PubMed ID: 24205020
[TBL] [Abstract][Full Text] [Related]
6. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
[TBL] [Abstract][Full Text] [Related]
7. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
Li QW; Lu CR; Ye M; Xiao WH; Liang J
Asian Pac J Cancer Prev; 2012; 13(1):191-4. PubMed ID: 22502666
[TBL] [Abstract][Full Text] [Related]
9. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
Wu D; Jiang H; Gu Q; Zhang D; Li Z
Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
[TBL] [Abstract][Full Text] [Related]
10. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
[TBL] [Abstract][Full Text] [Related]
11. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case-control study.
Saadat M; Kohan L; Omidvari S
Breast Cancer Res Treat; 2008 Oct; 111(3):549-53. PubMed ID: 17987379
[TBL] [Abstract][Full Text] [Related]
13. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
Natukula K; Jamil K; Pingali UR; Attili VS; Madireddy UR
Asian Pac J Cancer Prev; 2013; 14(9):5275-9. PubMed ID: 24175813
[TBL] [Abstract][Full Text] [Related]
14. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.
Pan Y; Zhao L; Chen XM; Gu Y; Shen JG; Liu LM
Asian Pac J Cancer Prev; 2013; 14(10):5761-7. PubMed ID: 24289575
[TBL] [Abstract][Full Text] [Related]
15. XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies.
Dai L; Wang K; Zhang J; Lv Q; Wu X; Wang Y
Int J Cancer; 2009 Sep; 125(5):1102-9. PubMed ID: 19444915
[TBL] [Abstract][Full Text] [Related]
16. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Chinese Han population: a meta-analysis.
Duan WH; Zhu ZY; Liu JG; Dong MS; Chen JZ; Liu QD; Xie Y; Sun TY; Gao ZF; Zhou NX
Asian Pac J Cancer Prev; 2012; 13(8):3601-4. PubMed ID: 23098440
[TBL] [Abstract][Full Text] [Related]
17. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
Xia S; Wu S; Wang M
Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
[TBL] [Abstract][Full Text] [Related]
18. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.
Huang Y; Xie D; Tang N; Wang J; Zeng X; Zhao P; He L
Tumour Biol; 2014 Jan; 35(1):799-808. PubMed ID: 23990457
[TBL] [Abstract][Full Text] [Related]
19. XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis.
Geng J; Zhang YW; Huang GC; Chen LB
World J Gastroenterol; 2008 Nov; 14(43):6733-7. PubMed ID: 19034980
[TBL] [Abstract][Full Text] [Related]
20. XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population.
Warchoł T; Mostowska A; Lianeri M; Lącki JK; Jagodziński PP
DNA Cell Biol; 2012 Jan; 31(1):50-6. PubMed ID: 21682595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
